世界の API 中間体市場 – 業界動向と 2030 年までの予測

Request for TOC TOC のリクエスト Speak to Analyst アナリストに相談する Buy Now今すぐ購入 Inquire Before Buying 事前に問い合わせる Free Sample Report 無料サンプルレポート

世界の API 中間体市場 – 業界動向と 2030 年までの予測

  • Pharmaceutical
  • Upcoming Report
  • Sep 2023
  • Global
  • 350 ページ
  • テーブル数: 220
  • 図の数: 60

世界の API 中間体市場

Market Size in USD Billion

CAGR :  % Diagram

Diagram 予測期間
2023 –2030
Diagram 市場規模(基準年)
USD 2.34 Billion
Diagram Market Size (Forecast Year)
USD 5.67 Billion
Diagram CAGR
%
Diagram Major Markets Players
  • HIKAL Ltd
  • Cambrex Corporation
  • Ganesh Group
  • AlzChem Group AG
  • Vasudha Pharma

>世界の API 中間体市場、タイプ別 (動物用医薬品中間体、医薬品 / バルク医薬品中間体)、製品別 (ブロモ化合物、O-ベンジルサルブタモール、ヘミ硫酸塩、オキシラン、ビソプロロール塩基、キラル PCBHP、フェニラミン塩基、クロルフェニラミン塩基、ブロムフェニラミン塩基、メピラミン / ピリラミン塩基、6-アミノ-1,3-ジメチルウラシル、テオフィリン、アセフィリン、キサンチン、ニトリル、その他)、治療タイプ別 (自己免疫疾患、腫瘍学、代謝性疾患、眼科、心血管疾患、感染症、神経学、呼吸器疾患、皮膚科、泌尿器科、その他)、顧客別 (直接ユーザー / 製薬会社、トレーダー / 卸売業者 / 販売業者、協会 / 政府機関 / 民間機関)、エンドユーザー別 (API製造業者、完成品製造業者)、流通チャネル(直接入札、小売販売、その他) - 2030 年までの業界動向と予測。

API中間体市場

世界の API 中間体市場の分析と規模

医薬品有効成分とは、 医薬品の製造に使用することを意図した物質または物質の組み合わせであり、医薬品の製造に使用されると医薬品有効成分になります。このような物質は、薬理活性を提供するために使用されます。             

Data Bridge Market Researchは、2022年に23億4,000万米ドルだった世界のAPI中間体市場は、2030年までに56億7,000万米ドルに達し、2023年から2030年の予測期間中に7.10%のCAGRを達成すると分析しています。「医薬品/バルク医薬品中間体」は、製薬業界の台頭により、世界のAPI中間体市場のタイプセグメントを支配しています。市場価値、成長率、セグメンテーション、地理的範囲、主要プレーヤーなどの市場シナリオに関する洞察に加えて、Data Bridge Market Researchがまとめた市場レポートには、詳細な専門家分析、患者疫学、パイプライン分析、価格分析、規制枠組みも含まれています。

API中間体市場の範囲とセグメンテーション

レポートメトリック

詳細

予測期間

2023年から2030年

基準年

2022

歴史的な年

2021 (2015~2021年にカスタマイズ可能)

定量単位

売上高(百万米ドル)、販売数量(個数)、価格(米ドル)

対象セグメント

タイプ (動物用医薬品中間体、医薬品 / バルク医薬品中間体)、製品 (臭素化合物、O-ベンジルサルブタモール、ヘミ硫酸塩、オキシラン、ビソプロロール塩基、キラル PCBHP、フェニラミン塩基、クロルフェニラミン塩基、ブロムフェニラミン塩基、メピラミン / ピリラミン塩基、6-アミノ-1,3-ジメチルウラシル、テオフィリン、アセフィリン、キサンチン、ニトリル、その他)、治療タイプ (自己免疫疾患、腫瘍学、代謝性疾患、眼科、心血管疾患、感染症、神経学、呼吸器疾患、皮膚科、泌尿器科、その他)、顧客 (直接ユーザー / 製薬会社、トレーダー / 卸売業者 / 販売業者、協会 / 政府機関 / 民間機関)、エンドユーザー (API メーカー、完成品メーカー)、流通チャネル(直接入札、小売販売、その他)

対象国

米国、カナダ、メキシコ、ドイツ、英国、フランス、イタリア、スペイン、オランダ、ロシア、スイス、トルコ、オーストリア、ノルウェー、ハンガリー、リトアニア、アイルランド、ポーランド、その他のヨーロッパ諸国、日本、中国、オーストラリア、インド、韓国、シンガポール、インドネシア、タイ、マレーシア、フィリピン、ベトナム、その他のアジア太平洋諸国、ブラジル、アルゼンチン、ペルー、その他の南米諸国、サウジアラビア、南アフリカ、UAE、イスラエル、クウェート、エジプト、その他の中東およびアフリカ諸国

対象となる市場プレーヤー

  • HIKAL Ltd. (インド)、Cambrex Corporation (米国)、Ganesh-Group、AlzChem Group AG (インド)、Vasudha Pharma (インド)、Anyang General Chemical Co.,Ltd. (中国)、Sarex (インド)、Sandoo Pharmaceuticals and Chemicals Co., Ltd (インド)、Atul Ltd (インド)、Sandoz International GmbH (Novartis AG の子会社) (ドイツ)、Aceto (米国)、Supriya Lifescience Ltd. (インド)、LEVACHEM COMPANY LIMITED (中国)、Vertellus (米国)、Dishman Carbogen Amcis Ltd (インド)、Sanofi (フランス)、Divi's Laboratories Limited (インド)、AARTI INDUSTRIES LIMITED (インド)、Aurobindo Pharma (インド)、BASF SE (ドイツ)

市場機会

  • 個別化医療の需要の高まり
  • コラボレーションとパートナーシップの拡大
  • グリーンで持続可能な化学への注目が高まる

市場の定義

医薬品と化学合成について議論する場合、「API 中間体」という用語は、医薬品有効成分 (API) を合成する長いプロセスを通じて生成される多くの化合物と材料を指します。医薬品の有効成分 (API) は、医薬品に治療効果をもたらすものです。API の作成には、多くの場合、多数の化学反応、精製手順、および原材料から目的の完成品への変換が伴います。このプロセスを通じてさまざまな中間化合物が生成され、それぞれが最終的な API への足がかりとして機能します。これらの中間体には、独自の化学的特性、構造、および用途がある場合があります。

世界の API 中間体市場の動向

ドライバー

  • 成長する製薬業界

人口の高齢化、医療費の高騰、斬新で独創的な治療法の需要などの要因により、医薬品ビジネスは世界的に成長を続けています。この拡大により、医薬品の製造に不可欠な成分である API 中間体の必要性が高まっています。

  • 技術の進歩の高まり

化学合成およびプロセス技術の発展により、API 中間体の製造の効率と費用対効果が向上し、市場拡大が促進されます。

  • バイオ医薬品の需要増加

バイオプロセス中間体に対する需要は、組み換えタンパク質やモノクローナル抗体などのバイオ医薬品の増加により拡大しています。これらのプロセスステップは生物製剤の製造に不可欠であり、市場の成長を促進しています。

機会

  • 個別化医療の需要の高まり

個別化医療や標的医薬品への傾向により、特定の患者プロファイルに合わせてカスタマイズされた API および中間体の開発が必要とされており、この分野の研究開発を刺激する可能性があります。

  • コラボレーションとパートナーシップの拡大

革新的なソリューションと新しい市場へのアクセスは、API 中間体生産者、製薬会社、研究機関間の連携から生まれます。

  • グリーンで持続可能な化学への注目の高まり

持続可能性と環境に優しい慣行への注目が高まるにつれ、API 中間体生産者には、より環境に優しく持続可能な化学プロセスと中間体を作成し、提供するチャンスがあります。

制約/課題

  • 厳しい規制

製薬業界では、厳格な規制が大きな障壁となる場合があります。適正製造規範 (GMP) などの規則を遵守し、それを維持するにはコストと時間がかかり、市場の成長が制限される可能性があります。

  • サプライチェーンの混乱

多くのメーカーが原材料や中間体の供給元として複雑なグローバル ネットワークに依存しているため、世界の API 中間体市場はサプライ チェーンの混乱に対して脆弱です。サプライ チェーンは、自然災害や政情不安などの予期せぬ状況によって妨げられる可能性があります。

  • 安全上の懸念

最優先事項は、産業プロセスのセキュリティと従業員の安全を確保することです。化学合成プロセスでは、危険な物質や反応が使用される可能性があります。

  • 高コスト  

API 中間体の製造における費用対効果とサプライ チェーンの安定性は、原材料や化学物質の価格や入手可能性の変化によって影響を受ける可能性があります。

このグローバル API 中間体市場レポートでは、最近の新しい開発、貿易規制、輸出入分析、生産分析、バリュー チェーンの最適化、市場シェア、国内および現地の市場プレーヤーの影響、新たな収益源の観点から見た機会の分析、市場規制の変更、戦略的市場成長分析、市場規模、カテゴリ市場の成長、アプリケーションのニッチと優位性、製品の承認、製品の発売、地理的拡大、市場における技術革新などの詳細が提供されます。グローバル API 中間体市場に関する詳細情報を取得するには、アナリスト ブリーフについて Data Bridge Market Research にお問い合わせください。当社のチームが、市場の成長を達成するための情報に基づいた市場決定を行うお手伝いをします。

世界の API 中間体市場の範囲

世界の API 中間体市場は、タイプ、製品、治療クラス、顧客、エンド ユーザー、流通チャネルに基づいてセグメント化されています。セグメント間の成長は、ニッチな成長分野と市場へのアプローチ戦略を分析し、コア アプリケーション領域とターゲット市場の違いを決定するのに役立ちます。

タイプ

  • 動物用医薬品中間体
  • 医薬品 / バルク医薬品中間体

製品

  • ブロモ化合物
  • O-ベンジルサルブタモール
  • ヘミ硫酸塩
  • オキシラン
  • ビソプロロール塩基
  • キラルPCBHP
  • フェニラミン塩基
  • クロルフェニラミン塩基
  • ブロムフェニラミン塩基
  • メピラミン/ピリラミン塩基
  • 6-アミノ-1,3-ジメチルウラシル
  • テオフィリン
  • アセフィリン
  • キサンチン
  • ニトリル
  • その他

治療の種類

  • 自己免疫疾患
  • 腫瘍学
  • 代謝性疾患
  • 眼科
  • 心血管疾患
  • 感染症
  • 神経学
  • 呼吸器疾患
  • 皮膚科
  • 泌尿器科
  • その他

顧客

  • 直接ユーザー/製薬会社
  • トレーダー/卸売業者/販売業者
  • 協会/政府機関/民間機関

エンドユーザー

  • APIメーカー
  • 完成品メーカー

流通チャネル

  • 直接入札
  • 小売販売
  • その他

世界の API 中間体市場の地域分析/洞察

世界の API 中間体市場が分析され、上記の国、タイプ、製品、治療タイプ、顧客、エンドユーザー、流通チャネルに基づいて市場規模の情報が提供されます。  

世界の API 中間体市場レポートで取り上げられている国は、米国、カナダ、メキシコ、ドイツ、英国、フランス、イタリア、スペイン、オランダ、ロシア、スイス、トルコ、オーストリア、ノルウェー、ハンガリー、リトアニア、アイルランド、ポーランド、その他のヨーロッパ諸国、日本、中国、オーストラリア、インド、韓国、シンガポール、インドネシア、タイ、マレーシア、フィリピン、ベトナム、その他のアジア太平洋諸国、ブラジル、アルゼンチン、ペルー、その他の南米諸国、サウジアラビア、南アフリカ、UAE、イスラエル、クウェート、エジプト、その他の中東およびアフリカ諸国です。

北米は世界の API 中間体市場で優位を占めており、医療費の増加と医薬品 / バルク医薬品中間体セグメント向けの確立された医療インフラにより、2023 年から 2030 年の予測期間に最高の成長率で成長すると予想されています。

アジア太平洋地域は世界の API 中間体市場の成長をリードしており、低コストでの API 中間体の入手可能性の増加により、医薬品 / バルク医薬品中間体セグメントが国内で優位を占めています。API 中間体の消費需要の増加により、ドイツの医薬品 / バルク医薬品中間体セグメントは世界の API 中間体市場で優位を占めています。

レポートの国別セクションでは、市場の現在および将来の傾向に影響を与える国内市場における個別の市場影響要因と規制の変更も提供しています。新規販売、交換販売、国の人口統計、規制行為、輸出入関税などのデータ ポイントは、各国の市場シナリオを予測するために使用される主要な指標の一部です。また、国別データの予測分析を提供する際には、グローバル ブランドの存在と可用性、および地元および国内ブランドとの競争が激しいか少ないために直面​​する課題、販売チャネルの影響も考慮されます。

ヘルスケアインフラの成長 導入ベースと新技術の浸透

 世界の API 中間体市場では、患者分析、予後、治療法に関する詳細な市場分析も提供されます。有病率、発症率、死亡率、遵守率は、レポートで利用できるデータ変数の一部です。疫学の市場成長への直接的または間接的な影響分析は、2023 ~ 2030 年の成長期間における市場を予測するための、より堅牢なコホート多変量統計モデルを作成するために分析されます。

競争環境と API 中間体市場シェア分析

 世界の API 中間体市場の競争状況は、競合他社ごとに詳細を提供します。含まれる詳細には、会社概要、会社の財務状況、生み出される収益、市場の可能性、研究開発への投資、新しい市場への取り組み、生産拠点と施設、会社の強みと弱み、製品の発売、製品試験パイプライン、製品の承認、特許、製品の幅と広さ、アプリケーションの優位性、技術ライフライン曲線などがあります。提供されている上記のデータ ポイントは、世界の API 中間体市場に関連する会社の焦点にのみ関連しています。

世界の API 中間体市場で活動している主要企業は次のとおりです。

  • HIKAL Ltd.(インド)
  • カンブレックスコーポレーション(米国)
  • Ganesh-Group、AlzChem Group AG(インド)
  • ヴァスダファーマ(インド)
  • 安陽総合化学株式会社(中国)
  • サレックス(インド)
  • サンドゥー製薬化学株式会社(インド)
  • アトゥル社(インド)
  • サンドス・インターナショナル GmbH(ノバルティス AG の子会社)(ドイツ)
  • アチェート(米国)
  • Supriya Lifescience Ltd.(インド)
  • LEVACHEM COMPANY LIMITED (中国)
  • バーテルス(米国)
  • Dishman Carbogen Amcis Ltd (インド)
  • サノフィ(フランス)
  • ディヴィス ラボラトリーズ リミテッド (インド)
  • AARTI INDUSTRIES LIMITED(インド)
  • オーロビンドファーマ(インド)
  • BASF SE(ドイツ)


SKU-

世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする

  • インタラクティブなデータ分析ダッシュボード
  • 成長の可能性が高い機会のための企業分析ダッシュボード
  • カスタマイズとクエリのためのリサーチアナリストアクセス
  • インタラクティブなダッシュボードによる競合分析
  • 最新ニュース、更新情報、トレンド分析
  • 包括的な競合追跡のためのベンチマーク分析のパワーを活用
デモのリクエスト

目次

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of GLOBAL API intermediates MARKET
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. type LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. vendor share analysis
    11. MARKET type COVERAGE GRID
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. premium insight
    1. CURRENT SCENARIO OF IMPORT AND EXPORT OF API INTERMEDIATE
    2. Tentative Production and operational costs calculations which will ultimately lead to feasibility of the product manufacturing
      1. Tentative Land requirement for a Substantial Production Capacity Plant Set-Up
    3. GLOBAL API INTERMEDIATES MARKET: 3C ANALYSIS-CHINA EFFECT
      1. THE U.S.-CHINA TRADE WAR
      2. INDO-CHINA GEOPOLITICAL ISSUES
      3. CHINESE SLOWDOWN DUE TO E&C OVER THE YEARS
      4. CHINESE SLOWDOWN DUE TO COVID-19 (CORONAVIRUS)
    4. Cost Analysis
    5. Analysis on China API intermediates:
      1. Conclusion:
    6. porters five forces model
    7. Pestel analysis
    8. global API INTERMEDIATES market: regulatORY
      1. THE U.S. REGULATORY GUIDANCE FOR NON-CLINICAL SAFETY EVALUATION OF API INTERMEDIATES
      2. CANADA REGULATORY GUIDANCE FOR API INTERMEDIATES
      3. EUROPE REGULATORY SCENARIO FOR API INTERMEDIATES
      4. JAPAN REGULATORY FOR API INTERMEDIATES
      5. MIDDLE EAST AND AFRICA REGULATORY FRAMEWORK FOR API INTERMEDIATES
  5. GLOBAL API INTERMEDIATES MARKET: CONCLUSION
    1. TOP PRODUCTS AND THERAPEUTIC AREAS
    2. ADDITIONAL
  6. CUSTOMER SENTIMENTS/INCLINATION TOWARDS FINDING ALTERNATE VENDOR SOURCE
  7. LIST OF API OR FORMULATION COMPANIES WITH API INTERMEDIATE:
  8. Market Overview
    1. Drivers
      1. HIGH BURDEN OF CHRONIC DISEASES
      2. increase in aging population
      3. utilization of advanceD technology in active pharmaceutical ingredients (api) manufacturing
      4. increasing disease awareness and education
      5. research and development regarding pharmaceutical API and their intermediates
    2. restrainTs
      1. availability of sub-standard and counterfeit drugs
      2. product recalls
      3. high manufacturing cost
      4. stringent government regulations for api intermediates
    3. opportunities
      1. strategic initiatives by the market players
      2. increasing healthcare expenditure
      3. SOARING NUMBER OF API INTERMEDIATES MANUFACTURERS
      4. RISE IN NUMBER OF CONTRACT MANUFACTURING ORGANIZATIONS (CMO) AND CONTRACT RESEARCH ORGANIZATIONS (crO)
    4. challenges
      1. disruption in the supply chain of active pharmaceutical ingredients (api) during covid-19
      2. lack of workforce in pharma industries
  9. Impact of COVID 19 on Global API Intermediates market
    1. IMPACT ON PRICE
    2. IMPACT ON DEMAND
    3. IMPACT ON SUPPLY CHAIIN
    4. STRATEGIC DECISIONS FOR MANUFACTURERS AFTER COVID-19 TO GAIN COMPETITIVE MARKET SHARE
    5. CONCLUSION
  10. global API intermediates MARKET, BY type
    1. overview
    2. pharmaceutical intermediates/ bulk drug intermediates
    3. Veterinary Drug Intermediates
  11. global API intermediates MARKET, BY product
    1. overview
    2. Nitriles
    3. bromo compound
    4. Chiral PCBHP
    5. Chlorpheniramine Base
    6. Brompheniramine Base
    7. Pheniramine Base
    8. O-Benzyl Salbutamol
    9. Bisoprolol Base
    10. Hemisulfate
    11. Oxirane
    12. Mepyramine/Pyrilamine Base
    13. Theofylline
    14. Acefylline
    15. Xanthine
    16. 6-Amino-1,3-Dimethyl Uracil
    17. others
  12. global API intermediates MARKET, BY therapeutic type
    1. overview
    2. Cardiovascular Diseases
    3. Metabolic Diseases
    4. infectious Diseases
    5. respiratory Diseases
    6. neurology
    7. oncology
    8. Autoimmune Disease
    9. Dermatology
    10. ophthalmology
    11. urology
    12. others
  13. global API intermediates MARKET, BY customers
    1. overview
    2. Direct Users/Pharma Companies
    3. Traders/Wholesalers/Distributors
    4. Associations/Govt. Institutions/Pvt Institutions
  14. global API intermediates MARKET, BY End User
    1. overview
    2. API manufacturer
    3. finished product manufacturer
  15. global API intermediates MARKET, BY distribution channel
    1. overview
    2. direct tender
    3. Retail Sale
    4. others
  16. Global API Intermediates Market by geography
    1. Overview
    2. NORTH AMERICA
      1. U.S
      2. CANADA
      3. MEXICO
    3. EUROPE
      1. GERMANY
      2. U.K
      3. ITALY
      4. SPAIN
      5. FRANCE
      6. NETHERLANDS
      7. RUSSIA
      8. SWITZERLAND
      9. TURKEY
      10. AUSTRIA
      11. NORWAY
      12. HUNGARY
      13. LITHUANIA
      14. IRELAND
      15. POLAND
      16. REST OF ASIA PACIFIC
    4. ASIA-PACIFIC
      1. CHINA
      2. INDIA
      3. JAPAN
      4. AUSTRALIA
      5. SOUTH KOREA
      6. SINGAPORE
      7. MALAYSIA
      8. THAILAND
      9. INDONESIA
      10. PHILIPPINES
      11. VIETNAM
      12. REST OF ASIA PACIFIC
    5. SOUTH AMERICA
      1. BRAZIL
      2. ARGENTINA
      3. PERU
      4. REST OF SOUTH AMERICA
    6. MIDDLE EAST & AFRICA
      1. SAUDI ARABIA
      2. SOUTH AFRICA
      3. UAE
      4. ISRAEL
      5. KUWAIT
      6. EGYPT
      7. REST OF MIDDLE EAST & AFRICA
  17. Global API Intermediates Market: COMPANY landscape
    1. company share analysis: global
    2. company share analysis: north america
    3. company share analysis: europe
    4. company share analysis: Asia-Pacific
  18. swot analysis
  19. company profile
    1. aurobindo pharma
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORFOLIO
      5. RECENT DEVELOPMENTS
    2. Divi’s laboratories limited
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    3. basf se
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    4. CAMBRIX CORPORATION
      1. COMPANY SNAPSHOT
      2. company share analysis
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    5. Sandoz International GmbH (a subsidiary of Novartis AG)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    6. aceto
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    7. hikal ltd.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    8. alzchem group ag
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    9. vertellus
      1. COMPANY SNAPSHOT
      2. PRODUCT CATEGORIES
      3. RECENT DEVELOPMENTS
    10. sanofi
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORFOLIO
      4. RECENT DEVELOPMENTS
    11. atul ltd
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    12. aarti industries limited
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    13. vasudha pharma
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    14. anyang general chemical co., Ltd.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORFOLIO
      3. RECENT DEVELOPMENT
    15. dishman carbogen amics ltd
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORFOLIO
      4. RECENT DEVELOPMENTS
    16. ganesh-group
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    17. levachem company limited
      1. COMPANY SNAPSHOT
      2. PRODUCT PORFOLIO
      3. RECENT DEVELOPMENT
    18. sandoo pharmaceuticals and chemicals co., ltd.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    19. sarex
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    20. SUPRIYA LIFESCIENCE LTD.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
  20. questionnaire
  21. related reports

表のリスト

TABLE 1 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS INTERMEDIATES: CUSTOMIZATION (COUNTRIES INVOLVED IN IMPORT & EXPORT)

TABLE 2 Percentage Break up of Cost

TABLE 3 Tentative Land Requirement

TABLE 4 Percentage Break up of Plant Area

TABLE 5 Table: 1 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS INTERMEDIATES: LIST OF API OR FORMULATION COMPANIES WITH API INTERMEDIATE

TABLE 6 HEALTHCARE EXPENDITURE IN ASIA-PACIFIC

TABLE 7 MARKET PLAYERS OF API INTERMEDIATES

TABLE 8 Sales Data of API intermediates for 2019/2020

TABLE 9 Global API intermediates Market, By Type, 2019-2028 (USD Million)

TABLE 10 Global pharmaceutical intermediates/ bulk drug intermediates in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 11 Global Veterinary Drug Intermediates in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 12 Global API intermediates Market, By Product, 2019-2028 (USD Million)

TABLE 13 Global nitriles in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 14 Global bromo compound in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 15 Global chiral PCBHP in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 16 Global chlorpheniramine base in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 17 Global brompheniramine base in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 18 Global pheniramine base in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 19 Global O-Benzyl Salbutamol in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 20 Global bisoprolol base in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 21 Global hemisulfate in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 22 Global oxirane in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 23 Global mepyramine/pyrilamine base in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 24 Global theofylline in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 25 Global acefylline in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 26 Global Xanthine in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 27 Global 6-amino-1, 3-dimethyl uracil in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 28 Global others in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 29 Global API intermediates Market, By THERAPEUTIC Type, 2019-2028 (USD Million)

TABLE 30 globaL cardiovascular diseases in API intermediates Market, By Region, 2017-2028 (USD Million)

TABLE 31 globaL metabolic diseases in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 32 globaLinfectious diseases in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 33 globaL respiratory diseases in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 34 globaL neurology in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 35 globaL oncology in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 36 globaL autoimmune diseases in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 37 globaL dermatology in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 38 globaL ophthalmology in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 39 globaL urology in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 40 globaL others in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 41 Global API intermediates Market, By CUSTOMERS, 2019-2028 (USD Million)

TABLE 42 globaL Direct Users/Pharma Companies in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 43 globaL Traders/Wholesalers/Distributors in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 44 globaL Associations/Govt. Institutions/Pvt Institutionsin API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 45 Global API intermediates Market, By END USER, 2019-2028 (USD Million)

TABLE 46 Global API manufacturer in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 47 Global finished product manufacturer in API intermediates Market, By region, 2019-2028 (USD Million)

TABLE 48 Global API intermediates Market, By distribution channel, 2019-2028 (USD Million)

TABLE 49 globaL direct tender in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 50 globaL retail sales in API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 51 globaL Othersin API intermediates Market, By Region, 2019-2028 (USD Million)

TABLE 52 GLOBAL ACTIVE PHARAMCEUTICAL INGREDIENTS MARKET, BY REGION , 2021-2028 (USD MILLION)

TABLE 53 NORTH AMERICA API INTERMEDIATES MARKET, BY COUNTRY, 2018-2028 (USD MILLION)

TABLE 54 North America API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 55 North America API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 56 North America API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 57 North America API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 58 North America API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 59 North America API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 60 U.S API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 61 U.S API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 62 U.S API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 63 U.S API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 64 U.S API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 65 U.S API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 66 Canada API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 67 Canada API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 68 Canada API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 69 Canada API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 70 Canada API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 71 Canada API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 72 MEXICO API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 73 MEXICO API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 74 MEXICO API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 75 MEXICO API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 76 MEXICO API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 77 MEXICO API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 78 Europe API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 79 Europe API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 80 Europe API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 81 Europe API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 82 Europe API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 83 Europe API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 84 Europe API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 85 Germany API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 86 Germany API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 87 Germany API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 88 Germany API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 89 Germany API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 90 Germany API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 91 U.K API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 92 U.K API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 93 U.K API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 94 U.K API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 95 U.K API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 96 U.K API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 97 U.K API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 98 Italy API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 99 Italy API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 100 Italy API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 101 Italy API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 102 Italy API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 103 Spain API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 104 Spain API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 105 Spain API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 106 Spain API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 107 Spain API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 108 Spain API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 109 France API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 110 France API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 111 France API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 112 France API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 113 France API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 114 France API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 115 Netherlands API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 116 Netherlands API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 117 Netherlands API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 118 Netherlands API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 119 Netherlands API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 120 Netherlands API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 121 Russia API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 122 Russia API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 123 Russia API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 124 Russia API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 125 Russia API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 126 Russia API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 127 Switzerland API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 128 Switzerland API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 129 Switzerland API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 130 Switzerland API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 131 Switzerland API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 132 Switzerland API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 133 Turkey API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 134 Turkey API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 135 Turkey API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 136 Turkey API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 137 Turkey API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 138 Turkey API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 139 Austria API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 140 Austria API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 141 Austria API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 142 Austria API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 143 Austria API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 144 Austria API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 145 Norway API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 146 Norway API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 147 Norway API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 148 Norway API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 149 Norway API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 150 Norway API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 151 Hungary API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 152 Hungary API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 153 Hungary API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 154 Hungary API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 155 Hungary API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 156 Hungary API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 157 Lithuania API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 158 Lithuania API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 159 Lithuania API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 160 Lithuania API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 161 Lithuania API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 162 Lithuania API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 163 Ireland API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 164 Ireland API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 165 Ireland API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 166 Ireland API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 167 Ireland API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 168 Ireland API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 169 Poland API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 170 Poland API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 171 Poland API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 172 Poland API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 173 Poland API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 174 Poland API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 175 Rest of Asia Pacific API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 176 ASIA-PACIFIC API INTERMEDIATES MARKET, BY COUNTRY, 2018-2028 (USD MILLION)

TABLE 177 Asia-Pacific API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 178 Asia-Pacific API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 179 Asia-Pacific API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 180 Asia-Pacific API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 181 Asia-Pacific API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 182 Asia-Pacific API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 183 China API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 184 China API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 185 China API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 186 China API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 187 China API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 188 China API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 189 India API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 190 India API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 191 India API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 192 India API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 193 India API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 194 India API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 195 India API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 196 Japan API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 197 Japan API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 198 Japan API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 199 Japan API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 200 Japan API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 201 australia API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 202 Australia API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 203 Australia API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 204 Australia API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 205 Australia API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 206 Australia API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 207 South Korea API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 208 South Korea API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 209 South Korea API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 210 South Korea API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 211 South Korea API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 212 South Korea API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 213 Singapore API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 214 Singapore API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 215 Singapore API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 216 Singapore API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 217 Singapore API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 218 Singapore API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 219 Malaysia API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 220 Malaysia API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 221 Malaysia API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 222 Malaysia API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 223 Malaysia API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 224 Malaysia API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 225 Thailand API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 226 Thailand API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 227 Thailand API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 228 Thailand API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 229 Thailand API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 230 Thailand API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 231 Indonesia API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 232 Indonesia API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 233 Indonesia API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 234 Indonesia API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 235 Indonesia API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 236 Indonesia API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 237 Philippines API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 238 Philippines API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 239 Philippines API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 240 Philippines API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 241 Philippines API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 242 Philippines API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 243 Vietnam API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 244 Vietnam API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 245 Vietnam API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 246 Vietnam API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 247 Vietnam API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 248 Vietnam API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 249 Rest of Asia Pacific API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 250 SOUTH AMERICA API INTERMEDIATES MARKET, BY COUNTRY, 2018-2028 (USD MILLION)

TABLE 251 South America API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 252 South America API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 253 South America API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 254 South America API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 255 South America API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 256 South America API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 257 BRAZIL API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 258 BRAZIL API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 259 BRAZIL API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 260 BRAZIL API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 261 BRAZIL API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 262 BRAZIL API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 263 Argentina API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 264 Argentina API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 265 Argentina API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 266 Argentina API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 267 Argentina API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 268 Argentina API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 269 PERU API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 270 PERU API intermediates market, By Product, 2019-2028 (USD Million)

TABLE 271 PERU API intermediates market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 272 PERU API intermediates market, By Customers, 2019-2028 (USD Million)

TABLE 273 PERU API intermediates market, By End User, 2019-2028 (USD Million)

TABLE 274 PERU API intermediates market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 275 Rest of South America API intermediates market, By Type, 2019-2028 (USD Million)

TABLE 276 MIDDLE EAST & AFRICA API INTERMEDIATES MARKET, BY COUNTRY, 2018-2028 (USD MILLION)

TABLE 277 Middle East & Africa API Intermediates Market, By Type, 2019-2028 (USD Million)

TABLE 278 Middle East & Africa API Intermediates Market, By Product, 2019-2028 (USD Million)

TABLE 279 Middle East & Africa API Intermediates Market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 280 Middle East & Africa API Intermediates Market, By Customers, 2019-2028 (USD Million)

TABLE 281 Middle East & Africa API Intermediates Market, By End User, 2019-2028 (USD Million)

TABLE 282 Middle East & Africa API Intermediates Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 283 Saudi Arabia API Intermediates Market, By Type, 2019-2028 (USD Million)

TABLE 284 Saudi Arabia API Intermediates Market, By Product, 2019-2028 (USD Million)

TABLE 285 Saudi Arabia API Intermediates Market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 286 Saudi Arabia API Intermediates Market, By Customers, 2019-2028 (USD Million)

TABLE 287 Saudi Arabia API Intermediates Market, By End User, 2019-2028 (USD Million)

TABLE 288 Saudi Arabia API Intermediates Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 289 South Africa API Intermediates Market, By Type, 2019-2028 (USD Million)

TABLE 290 South Africa API Intermediates Market, By Product, 2019-2028 (USD Million)

TABLE 291 South Africa API Intermediates Market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 292 South Africa API Intermediates Market, By Customers, 2019-2028 (USD Million)

TABLE 293 South Africa API Intermediates Market, By End User, 2019-2028 (USD Million)

TABLE 294 South Africa API Intermediates Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 295 UAE API Intermediates Market, By Type, 2019-2028 (USD Million)

TABLE 296 UAE API Intermediates Market, By Product, 2019-2028 (USD Million)

TABLE 297 UAE API Intermediates Market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 298 UAE API Intermediates Market, By Customers, 2019-2028 (USD Million)

TABLE 299 UAE API Intermediates Market, By End User, 2019-2028 (USD Million)

TABLE 300 UAE API Intermediates Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 301 Israel API Intermediates Market, By Type, 2019-2028 (USD Million)

TABLE 302 Israel API Intermediates Market, By Product, 2019-2028 (USD Million)

TABLE 303 Israel API Intermediates Market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 304 Israel API Intermediates Market, By Customers, 2019-2028 (USD Million)

TABLE 305 Israel API Intermediates Market, By End User, 2019-2028 (USD Million)

TABLE 306 Israel API Intermediates Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 307 Kuwait API Intermediates Market, By Type, 2019-2028 (USD Million)

TABLE 308 Kuwait API Intermediates Market, By Product, 2019-2028 (USD Million)

TABLE 309 Kuwait API Intermediates Market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 310 Kuwait API Intermediates Market, By Customers, 2019-2028 (USD Million)

TABLE 311 Kuwait API Intermediates Market, By End User, 2019-2028 (USD Million)

TABLE 312 Kuwait API Intermediates Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 313 Egypt API Intermediates Market, By Type, 2019-2028 (USD Million)

TABLE 314 Egypt API Intermediates Market, By Product, 2019-2028 (USD Million)

TABLE 315 Egypt API Intermediates Market, By Therapeutic Type, 2019-2028 (USD Million)

TABLE 316 Egypt API Intermediates Market, By Customers, 2019-2028 (USD Million)

TABLE 317 Egypt API Intermediates Market, By End User, 2019-2028 (USD Million)

TABLE 318 Egypt API Intermediates Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 319 Rest of Middle East & Africa API Intermediates Market, By Type, 2019-2028 (USD Million)

図表一覧

FIGURE 1 Global API INTERMEDIATES MARKET: SEGMENTATION

FIGURE 2 GLOBAL API INTERMEDIATES MARKET: DATA TRIANGULATION

FIGURE 3 global API intermediates Market: DROC ANALYSIS

FIGURE 4 Global API intermediates market: Global VS REGIONAL MARKET ANALYSIS

FIGURE 5 Global API intermediates Market: COMPANY RESEARCH ANALYSIS

FIGURE 6 GLOBAL API intermediates MARKET: MULTIVARIATE MODELLING

FIGURE 7 GLOBAL API intermediates MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 GLOBAL API INTERMEDIATES MARKET: DBMR MARKET POSITION GRID

FIGURE 9 GLOBAL API INTERMEDIATES MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 GLOBAL API intermediates MARKET: MARKET type COVERAGE GRID

FIGURE 11 Global API intermediates market: SEGMENTATION

FIGURE 12 NORTH AMERICA is expected to DOMINATE THE GLOBAL API intermediates market AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 13 north america is the fastest growing market FOR the API intermediates MANUFACTURERS IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 14 Utilization of advanceD technology in active pharmaceutical ingredients (API) manufacturing is DRIVing THE global API intermediates MARKET IN THE FORECAST PERIOD OF 2021 to 2028

FIGURE 15 pharmaceutical / bulk drug intermediates SEGMENT is expected to account for the largest share of the global API INTERMEDIATES MARKET in 2021 & 2028

FIGURE 16 DRIVERS, RESTRAINTs, OPPORTUNITies AND CHALLENGEs OF Global API Intermediates market

FIGURE 17 TOP 5 COUNTRIES FOR NUMBER OF PEOPLE AGED 20 TO 79 SUFFERING FROM DIABETES in 2019

FIGURE 18 ESTIMATED NUMBER OF DIFFERENT TYPEs OF CANCERS IN FEMALE POPULATION in 2020

FIGURE 19 ESTIMATED NUMBER OF DIFFERENT TYPEs OF CANCERS IN MALE POPULATION in 2020

FIGURE 20 10 GLOBAL CAUSES OF DEATHs WITH THE CHRONIC DISEASES

FIGURE 21 NUMBER OF PERSON AGED 60 YEARS OR OVER BY REGIONS in 2020 (IN MILLIONS)

FIGURE 22 MARKET GROWTH IN CLINICAL CRO (IN USD MILLIONS)

FIGURE 23 global API intermediates market: BY type, 2021

FIGURE 24 global API intermediates market: BY type, 2019-2028 (USD Million)

FIGURE 25 global API intermediates market: BY type, CAGR (2021-2028)

FIGURE 26 global API intermediates market: BY type, LIFELINE CURVE

FIGURE 27 global API intermediates market: BY product, 2021

FIGURE 28 global API intermediates market: BY product, 2019-2028 (USD Million)

FIGURE 29 global API intermediates market: BY product, CAGR(2021-2028)

FIGURE 30 global API intermediates market: BY product, LIFELINE CURVE

FIGURE 31 global API intermediates market: BY therapeutic type, 2021

FIGURE 32 global API intermediates market: BY therapeutic type, 2019-2028 (USD Million)

FIGURE 33 global API intermediates market: BY therapeutic type, CAGR (2021-2028)

FIGURE 34 global API intermediates market: BY therapeutic type, LIFELINE CURVE

FIGURE 35 global API intermediates market: BY customers, 2021

FIGURE 36 global API intermediates market: BY customers, 2019-2028 (USD Million)

FIGURE 37 global API intermediates market: BY customers, CAGR (2021-2028)

FIGURE 38 global API intermediates market: BY customers, LIFELINE CURVE

FIGURE 39 global API intermediates market: BY end user, 2021

FIGURE 40 global API intermediates market: BY end user, 2019-2028 (USD Million)

FIGURE 41 global API intermediates market: BY end user, CAGR (2021-2028)

FIGURE 42 global API intermediates market: BY end user, LIFELINE CURVE

FIGURE 43 global API intermediates market: BY distribution channel, 2021

FIGURE 44 global API intermediates market: BY distribution channel, 2019-2028 (USD Million)

FIGURE 45 global API intermediates market: BY distribution channel, CAGR (2021-2028)

FIGURE 46 global API intermediates market: BY distribution channel, LIFELINE CURVE

FIGURE 47 GLOBAL ACTIVE PHARAMCEUTICAL INGREDIENTS market: SNAPSHOT (2020)

FIGURE 48 GLOBAL ACTIVE PHARAMCEUTICAL INGREDIENTS market: BY COUNTRY (2020)

FIGURE 49 GLOBAL ACTIVE PHARAMCEUTICAL INGREDIENTS market: BY COUNTRY (2021 & 2028)

FIGURE 50 GLOBAL ACTIVE PHARAMCEUTICAL INGREDIENTS market: BY COUNTRY (2020 & 2028)

FIGURE 51 GLOBAL ACTIVE PHARAMCEUTICAL INGREDIENTS market: BY type (2021-2028)

FIGURE 52 North America API Intermediates market: SNAPSHOT (2020)

FIGURE 53 North America API Intermediates market: BY COUNTRY (2020)

FIGURE 54 North America API Intermediates market: BY COUNTRY (2021 & 2028)

FIGURE 55 North America API Intermediates market: BY COUNTRY (2020 & 2028)

FIGURE 56 North America API Intermediates market: BY type (2021-2028)

FIGURE 57 Europe API Intermediates market: SNAPSHOT (2020)

FIGURE 58 Europe API INTERMEDIATEs market: BY COUNTRY (2020)

FIGURE 59 Europe API INTERMEDIATEs market: BY COUNTRY (2021 & 2028)

FIGURE 60 Europe API Intermediates market: BY COUNTRY (2020 & 2028)

FIGURE 61 Europe API Intermediates market: BY type (2021-2028)

FIGURE 62 Asia-Pacific API Intermediates market: SNAPSHOT (2020)

FIGURE 63 Asia-Pacific API Intermediates market: BY COUNTRY (2020)

FIGURE 64 Asia-Pacific API Intermediates market: BY COUNTRY (2021 & 2028)

FIGURE 65 Asia-Pacific API Intermediates market: BY COUNTRY (2020 & 2028)

FIGURE 66 Asia-Pacific API Intermediates market: BY type (2021-2028)

FIGURE 67 South America API Intermediates market: SNAPSHOT (2020)

FIGURE 68 South America API Intermediates market: BY COUNTRY (2020)

FIGURE 69 South America API Intermediates market: BY COUNTRY (2021 & 2028)

FIGURE 70 South America API Intermediates market: BY COUNTRY (2020 & 2028)

FIGURE 71 South America API Intermediates market: BY type (2021-2028)

FIGURE 72 Middle East & Africa API Intermediates market: SNAPSHOT (2020)

FIGURE 73 Middle East & Africa API Intermediates market: BY COUNTRY (2020)

FIGURE 74 Middle East & Africa API Intermediates market: BY COUNTRY (2021 & 2028)

FIGURE 75 Middle East & Africa API Intermediates market: BY COUNTRY (2020 & 2028)

FIGURE 76 Middle East & Africa API Intermediates market: BY type (2021-2028)

FIGURE 77 Global API Intermediates market: company share 2020 (%)

FIGURE 78 North America API Intermediates Market: company share 2020 (%)

FIGURE 79 EUROPE API Intermediates Market: company share 2020 (%)

FIGURE 80 ASIA-PACIFIC API Intermediates Market: company share 2020 (%)

詳細情報を見る Right Arrow

調査方法

データ収集と基準年分析は、大規模なサンプル サイズのデータ​​収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。

DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。

カスタマイズ可能

Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。

Frequently Asked Questions

The market is segmented based on Global API Intermediates Market, By Type (Veterinary Drug Intermediates, Pharmaceutical / Bulk Drug Intermediates), Product (Bromo Compound, O-Benzyl Salbutamol, Hemisulfate, Oxirane, Bisoprolol Base, Chiral PCBHP, Pheniramine Base, Chlorpheniramine Base, Brompheniramine Base, Mepyramine/Pyrilamine Base, 6-Amino-1,3-Dimethyl Uracil, Theofylline, Acefylline, Xanthine, Nitriles, Others), Therapeutic Type (Autoimmune Diseases, Oncology, Metabolic Diseases, Ophthalmology, Cardiovascular Diseases, Infectious Diseases, Neurology, Respiratory Disorders, Dermatology, Urology, Others), Customers (Direct Users/Pharma Companies, Traders/Wholesalers/Distributors, Associations/Govt. Institutions/Pvt Institutions), End User (API Manufacturer, Finished Product Manufacturer), Distribution Channel (Direct Tender, Retail Sales, Others) - Industry Trends and Forecast to 2030. .
The Global Api Intermediates Market size was valued at USD 2.34 USD Billion in 2022.
The Global Api Intermediates Market is projected to grow at a CAGR of 7.1% during the forecast period of 2023 to 2030.
The major players operating in the market include HIKAL Ltd, Cambrex Corporation, Ganesh Group, AlzChem Group AG, Vasudha Pharma, Anyang General Chemical Co., Sarex, Sandoo Pharmaceuticals and Chemicals Co., Atul Ltd, Sandoz International GmbH, Aceto, Supriya Lifescience , LEVACHEM COMPANY LIMITED, Vertellus, Dishman Carbogen Amcis Ltd, Sanofi, Divi's Laboratories Limited, AARTI INDUSTRIES LIMITED, Aurobindo Pharma, BASF SE.
The market report covers data from the U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, Rest of Europe, Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Rest of Asia-Pacific, Brazil, Argentina, Peru, Rest of South America, Saudi Arabia, South Africa, UAE, Israel, Kuwait, Egypt and Rest of Middle East and Africa.